Cargando…

MON-LB080 Change of T2-Weighted Intensity of Prolactinoma as a Predictable Value for Relapse of Hyperprolactinemia after Cabergoline Withdrawal

Background The aim of this study were to assess whether change of T2 weighted signal intensity (T2-WSI) on magnetic resonance imaging (MRI) is associated with complete remission after cabergoline withdrawal in patients with prolactinoma. Methods In a retrospective cohort study, we identified 631 pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kyungwon, Ku, Cheol Ryong, Kim, Daham, Lee, Eun-Jig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550967/ http://dx.doi.org/10.1210/js.2019-MON-LB080

Ejemplares similares

MON-LB60 Prolactin Response to Metformin in Cabergoline-Resistant Prolactinomas: A Prospective Study
por: Corrêa Portari, Luiz Henrique, et al.
Publicado: (2020)

SUN-446 Association between Prolactin Level and Tumor Size Reduction at 3 Months after Cabergoline Treatment in Patients with Macroprolactinoma
por: Kim, Daham, et al.
Publicado: (2019)

MON-436 Clinical Phenotypes of GNAS Gene Mutations in Acromegalic Patients
por: Jung, Hyein, et al.
Publicado: (2019)

FRI322 Lack Of Tumor Size Change With Long-term Cabergoline For Prolactinoma
por: Bendaram, Snigdha Reddy, et al.
Publicado: (2023)

SAT-474 Giant Prolactinoma Case Series Assessing Response on Initial Dose of Cabergoline
por: Madan Paramasivan, Ameena, et al.
Publicado: (2019)

SAT-246 A Case of Cabergoline Induced Pituitary Apoplexy in a Patient with Prolactinoma
por: Ahuja, Ashim
Publicado: (2020)

FRI321 Aggressive Prolactinoma Empirically Treated With Cabergoline Leading To Rapid CSF Leak
por: Yau, Alice, et al.
Publicado: (2023)

SAT-LB47 Tension Pneumothorax Following Cabergoline Initiation for Macroprolactinoma
por: Go, Muriel Tania, et al.
Publicado: (2020)

SAT-LB080 Peptide Receptor Radionuclide Therapy in Metastatic Pheochromocytoma and Paraganglioma: The Putrajaya Experience
por: Wong, Hui, et al.
Publicado: (2019)

SUN-LB073 Giant Prolactinomas: Recidive (Case Report)
por: Galesanu, Corina
Publicado: (2019)

SUN-445 A Brazilian Multicentric Study Evaluating Pregnancies Induced by Cabergoline in Patients Harboring Prolactinomas
por: Sant Anna, Beatriz, et al.
Publicado: (2019)

MON-266 The Association Between Prolactinomas and Weight Gain
por: Tariq, Zunera, et al.
Publicado: (2020)

FRI297 Hemoglobin Decline As A Signal For Hyperprolactinemia Onset Prior To Prolactinoma Diagnosis In Hypogonadal Men
por: Rudman, Yaron, et al.
Publicado: (2023)

MON-258 Hyperprolactinemia: An Unusual Initial Presenting Manifestation of Multiple Sclerosis
por: Hodge, MaKenzie, et al.
Publicado: (2020)

SAT-436 Adjuvant Therapeutic Modalities in Acromegaly: Clinical Course and Factors Predicting Biochemical Controls
por: Jung, Hyein, et al.
Publicado: (2019)

MON-LB46 Thyrotropinoma and Pregnancy
por: Namboodiri, Divya, et al.
Publicado: (2020)

SUN-LB080 ACROSTUDY - Safety and Efficacy of a Cohort of 110 Naïve Patients with Acromegaly Treated with Pegvisomant
por: Wajnrajch, Michael, et al.
Publicado: (2019)

MON-282 Treatment of Hyperprolactinemia with Ropinirole: An Open-Label Dose Escalation Study
por: Tsang, Amanda, et al.
Publicado: (2020)

ODP328 Longitudinal Multidisciplinary Approach for Cabergoline-Resistant Aggressive Prolactinoma Complicated by Multiple Endocrine Neoplasia Type 1
por: Furusawa, Sho, et al.
Publicado: (2022)

MON-312 The Effects of Cabergoline in Pre-Surgical and Recurrence Periods of Cushing’s Disease Patients
por: Pereira, Ana Julia Garcia, et al.
Publicado: (2020)

MON-324 Management and Therapeutic Response Comparison in Prolactinomas According to Tumor Size
por: Flores-Cardenas, Romina
Publicado: (2020)

MON-427 An Interesting Case of Drug-Induced Hyperprolactinemia in a Patient Who Presented with Psychosis
por: Siddiqi, Asmat, et al.
Publicado: (2019)

MON-275 Prolactin to Testosterone Ratio Predicts Pituitary Pathology in Hypogonadal Men with Mild Hyperprolactinemia
por: Naelitz, Bryan D, et al.
Publicado: (2020)

MON-LB48 The Genomic Landscape of Sporadic Thyrotrophinomas
por: shen, Angeline, et al.
Publicado: (2020)

MON-LB52 Evaluation of Arterial Stiffness in Acromegaly Patients
por: alagüney, sevil, et al.
Publicado: (2020)

MON-293 The Prevalence of Impulse Control Disorders in Patients with Acromegaly and Prolactinomas Treated with Dopamine Agonists
por: Ozkaya, Hande Mefkure, et al.
Publicado: (2020)

MON-LB081 Pituitary Adenomas: A Pan-genomic Classification
por: NEOU, Mario, et al.
Publicado: (2019)

Drug Induced Hyperprolactinemia
por: Venkatanarasu, Ashok, et al.
Publicado: (2021)

MON-LB070 Lymphocytic Infundibulo-Neurohypophysitis Producing Regressive Postpartum Diabetes Insipidus
por: Ghervan, Cristina, et al.
Publicado: (2019)

MON-LB59 Radiofrequency Ablation as a Primary Therapy for Benign Functioning Insulinoma
por: Alyusuf, Ebtihal Y, et al.
Publicado: (2020)

SAT-270 Priapism Secondary to Cabergoline
por: Amir, Maryam, et al.
Publicado: (2020)

MON-LB082 Elevated Expression of KISSR Is Associated with Secretory Function of Functioning Gonadotroph Adenomas
por: Wang, Linjie, et al.
Publicado: (2019)

MON-LB078 Desmopressin Stimulated Salivary Cortisol as a Suplementary Tool in the Diagnosis of Cushing's Syndrome
por: Firme, Ricardo
Publicado: (2019)

MON-LB069 When a Routine Postoperative Internal Medicine Consultation Unearths a Hidden Diagnosis
por: Chengappa, Madhuri, et al.
Publicado: (2019)

MON-LB072 Primary Partial Empty Sella Presenting with Prepubertal Hypogonadotropic Hypogonadism: A Case Report
por: Matabang, Maria Angela, et al.
Publicado: (2019)

MON-LB58 The Use of 11C Methionine PET CT In Localization of ACTH Dependent Cushing’s Disease
por: ElEbrashy, Shady Ibrahim, et al.
Publicado: (2020)

SAT612 Granulomatous Mastitis: An Unusual Presentation Of Prolactinoma
por: Alkaissi, Hussam R, et al.
Publicado: (2023)

THU072 Association Between Nonalcoholic Fatty Liver Disease And Growth Hormone Deficiency In Patients With Nonfunctioning Pituitary Adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

MON-LB071 Panhypopituitarism Causing a Life Threatening Prolonged QT Interval Which Can Be Reversible with Treatment of Underlying Endocrine Disorders
por: Sittol, Rani, et al.
Publicado: (2019)

Acute Ischaemic Stroke With Hyperprolactinemia:A Case Report
por: Wan Zain, Wan Mohd Saifuhisam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1nel0n089he0ruo4q4bcoo43b2